KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Share-based Compensation Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -0.67%
Dec 31, 2025 -4.90%
Sep 30, 2025 -5.56%
Jun 30, 2025 -8.45%
Mar 31, 2025 -7.27%
Dec 31, 2024 -15.83%
Sep 30, 2024 18.16%
Jun 30, 2024 21.10%
Mar 31, 2024 20.20%
Dec 31, 2023 19.10%
Sep 30, 2023 16.32%
Jun 30, 2023 21.85%
Mar 31, 2023 17.27%
Dec 31, 2022 18.94%
Sep 30, 2022 18.13%
Jun 30, 2022 16.52%
Mar 31, 2022 18.91%
Dec 31, 2021 18.89%
Sep 30, 2021 24.23%
Jun 30, 2021 23.79%
Mar 31, 2021 26.29%
Dec 31, 2020 23.72%
Sep 30, 2020 24.04%
Jun 30, 2020 29.27%
Mar 31, 2020 31.21%
Dec 31, 2019 33.89%
Sep 30, 2019 3.13%
Jun 30, 2019 -0.81%
Mar 31, 2019 1.58%
Dec 31, 2018 0.77%
Sep 30, 2018 6.62%
Jun 30, 2018 2.09%
Mar 31, 2018 2.34%
Dec 31, 2017 1.68%
Sep 30, 2017 -16.06%
Jun 30, 2017 6.19%
Mar 31, 2017 1.39%
Dec 31, 2016 6.43%
Sep 30, 2016 4.24%
Jun 30, 2016 4.66%
Mar 31, 2016 4.34%
Dec 31, 2015 3.37%
Sep 30, 2015 6.03%
Jun 30, 2015 3.78%
Mar 31, 2015 2.82%
Dec 31, 2014 4.48%
Sep 30, 2014 2.71%